Brigit Biofarmaka Teknologi Tbk. vs Pradiksi Gunatama Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Pradiksi Gunatama Tbk. trades at Rp7,700 (market cap 42.32T, 72.4K 24h volume). The key difference: Pradiksi Gunatama Tbk. is far larger — about 244.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (218.7K versus 72.4K). Which is the better fit depends on your goals.
| OBAT | PGUN | |
|---|---|---|
Market Cap | 172.82B | 42.32T |
Volume | 218.7K | 72.4K |
Lot | 2.19K | 724 |
Turnover | 53.51M | 545.13M |
Average Price | 244.66 | 7,529.45 |
Value | 53.51M | 545.13M |
Indicative Equilibrium Price | 252 | 7,700 |
Indicative Equilibrium Volume | 48 | 65 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pradiksi Gunatama Tbk (Company), was established on September 11, 1995 in the Republic of Indonesia in the framework of foreign investment in accordance with the Domestic Investment Law No. 1 of 1989, Juncto Law No. 12 of 1970, based on deed No. 46 dated June 21, 1996 notary Ny. Toety Juniarto.SH in Jakarta. The Company commenced commercial operations in 2002.
Read more on PGUN →